Molbio Diagnostics Limited (NSE:MOLBIO)
India flag India · Delayed Price · Currency is INR
1,094.75
-49.40 (-4.32%)
Aug 28, 2026, 3:29 PM IST

Molbio Diagnostics Company Description

Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases.

It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors.

It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders.

In addition, the company offers Truenat, a multi-disease real-time polymerase chain reaction platform that enables treatment decisions for various infectious and non-communicable diseases, such as tuberculosis, human immunodeficiency virus, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc.; and Truenat assays.

The company was incorporated in 2000 and is based in Verna, India.

Molbio Diagnostics Limited
CountryIndia
Founded2000
IndustryMedical - Specialties
SectorHealthcare
Employees1,225
CEOSriram Natarajan

Contact Details

Address:
Plot No. L-46
Verna, 403722
India
Phone91 83 2672 4888
Websitemolbiodiagnostics.com

Stock Details

Ticker SymbolMOLBIO
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE869T01028
SIC Code2835

Key Executives

NamePosition
Sriram NatarajanChief Executive Officer
Manan KhokhaniChief Financial Officer
Sangeetha SriramChief Operating Officer
Indraneil BorkakotyHead of Investor Relations